Biotech / PharmaPittsburgh
Peptilogics
Biotech / Pharma
Peptilogics is a clinical-stage surgical therapeutics company developing novel anti-biofilm drugs to cure and prevent medical device-related infections (MDRI). Its lead asset, Zaloganan, advanced into a pivotal clinical trial following a $78 million funding round announced in October 2025.
Founded
Region
Pittsburgh
Investors
People